Home / Inspections / 1211177

FDA Inspection 1211177 — SGS North America Inc.

SGS North America Inc. — FEI 2214690

The FDA completed an inspection of SGS North America Inc. on August 1, 2023 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 1, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fairfield, NJ (United States)

Facility

Other inspections at this facility

  • 1321138 (VAI Tue Jun 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027721 (NAI Wed Aug 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 973286 (NAI Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 862181 (VAI Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 753526 (NAI Mon Nov 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources